title: Donor outcomes in right lobe adult living donor liver transplantation: single-center experience in Egypt.
abstract: OBJECTIVE
  Living donor liver transplantation (LDLT) is an alternative source of organs for patients with end-stage liver disease (ESLD) in absence of deceased donor LT. In LDLT the greatest concern is donor safety. Our objective was to evaluate the outcome of donors after right lobe liver donation in a single LT center in Egypt.
  
  
  METHODS
  Fifty LDL resections were performed from 2001 to 2004. The mean donor age was 29.2 +/- 6.4 years. Residual liver volume was 41.1 +/- 4.5%. Mean operative time was 560 +/- 62.2 minutes; mean ICU stay, less than 24 hours; mean hospital stay, 15.4 +/- 7.7 days; and mean follow-up period, 6 months.
  
  
  RESULTS
  There was no mortality. The overall complication rate was 68% (34 donors). Major complications included intraoperative bleeding in one, biliary leak in two, and pneumonia in three donors. Minor complications included mild pleural effusion in 13 donors, transient ascites in 10, mild depression in 7, intra-abdominal collections in 3, and wound infections in 1 donor. Residual liver volume did not affect the complication rate. None required reoperation. Return to predonation activity occurred within 6 to 8 weeks. No liver impairment occurred during follow-up.
  
  
  CONCLUSIONS
  Right lobe adult LDLT is a safe procedure with regard to donor outcome. Major complications occurred in only 10% of our series.
authors.affiliation: Tropical Medicine, Cairo University, Cairo, Egypt. Gesmat@umbegypt.com
authors.forename: G
authors.initials: G
authors.lastname: Esmat
authors.forename: A
authors.initials: A
authors.lastname: Yosry
authors.forename: M
authors.initials: M
authors.lastname: El-Serafi
authors.forename: A
authors.initials: A
authors.lastname: Omar
authors.forename: W
authors.initials: W
authors.lastname: Doss
authors.forename: A
authors.initials: A
authors.lastname: Hosny
authors.forename: A
authors.initials: A
authors.lastname: Ghali
authors.forename: H
authors.initials: H
authors.lastname: Sabry
authors.forename: H
authors.initials: H
authors.lastname: Attia
authors.forename: S
authors.initials: S
authors.lastname: Kamel
authors.forename: M
authors.initials: M
authors.lastname: Said
authors.forename: H
authors.initials: H
authors.lastname: Gabali
authors.forename: S K
authors.initials: SK
authors.lastname: Lee
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
mesh_terms: D000328:Adult; D016063:Blood Loss, Surgical; D002758:Cholangiography; D002763:Cholecystectomy; D004534:Egypt; D006498:Hepatectomy / Q000009:adverse effects / Q000379:methods*; D006499:Hepatic Artery / Q000601:surgery; D006503:Hepatic Veins / Q000601:surgery; D006801:Humans; D007902:Length of Stay; D017093:Liver Failure / Q000601:surgery; D016031:Liver Transplantation / Q000379:methods*; D018579:Patient Selection; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D020858:Tissue and Organ Harvesting / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome